The first session of the Clinical Year in Review series at the ATS 2024 International Conference summarized recent research concerning acute respiratory distress syndrome (ARDS), asthma, health equity, and lung cancer.

The Clinical Year in Review series continued at ATS 2024, recounting critical findings related to COPD, critical care medicine, global lung health data, and tuberculosis.

The third day of the Clinical Year in Review series at ATS 2024 in San Diego focused on impactful research regarding several distinct lung diseases, sepsis, and medical education strategies.

The final Clinical Year in Review at this year’s International Conference featured investigations in tobacco abstinence, extracorporeal membrane oxygenation (ECMO), pulmonary vascular disease, and sleep medicine.

The ATS MECOR Program celebrated the 30th anniversary of its mission to empower local scientists in low- and middle-income countries to address the burden of respiratory diseases through advanced research methods at ATS 2024.